Clinical Trials Browser

Phase 1 × vorolanib × Gastrointestinal × Clear all

NCT03511222 2020-07-29

Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms

NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

Phase 1 Unknown

Gastrointestinal

Advanced Gastric Cancer